Sunday, April 20, 2025

Yearly Archives: 2020

Sanofi: First patient outside U.S. treated in global Kevzara® (sarilumab) clinical trial program for patients with severe COVID-19

On 30-Mar-2020, Sanofi announced that "The first patient outside of the U.S. has been treated as part of a global clinical program evaluating Kevzara® (sarilumab)...

Amgen And Adaptive Biotechnologies Announce Strategic Partnership To Develop A Therapeutic To Prevent Or Treat COVID-19

On 02-April-2020, "Amgen and Adaptive technologies announced a collaboration aimed at helping address the COVID-19 pandemic. The companies will combine expertise to discover and develop...

Coronavirus (COVID-19) Update: FDA Coordinates National Effort to Develop Blood-Related Therapies for COVID-19

On 03-April-2020, The U.S. Food and Drug Administration continues to play a critical role in accelerating medical countermeasures to treat and prevent COVID-19. As...

Imfinzi approved in the US for extensive-stage small cell lung cancer

On 30-Mar-2020, AstraZeneca announced that "its Imfinzi (durvalumab) has been approved in the US as a 1st-line treatment for adult patients with extensive-stage small cell lung...

Farxiga reduced the incidence of heart failure worsening or cardiovascular death in a sub-analysis from landmark Phase III DAPA-HF trial

On 28-Mar-2020, AstraZeneca announced that "new data from a sub-analysis of the landmark Phase III DAPA-HF (Dapagliflozin And Prevention of Adverse-outcomes in Heart Failure)...

Farxiga Phase III DAPA-CKD trial will be stopped early after overwhelming efficacy in patients with chronic kidney disease

On 30-Mar-2020, AstraZeneca announced that "The Dapagliflozin And Prevention of Adverse outcomes in Chronic Kidney Disease (DAPA-CKD) Phase III trial for Farxiga (dapagliflozin) in patients with chronic kidney disease (CKD) will be stopped...

EMA Accepts Arvelle Therapeutics’ MAA for Cenobamate for the Adjunctive Treatment of Focal-Onset Seizures in Adults

On 26-Mar-2020, SK Biopharmaceuticals Co., Ltd. announced the "European Medicines Agency (EMA) acceptance of Arvelle Therapeutics' Marketing Authorization Application (MAA) for cenobamate, an...

CHMP gives Sanofi positive opinion for Sarclisa for the treatment of relapsed and refractory multiple myeloma

On 27-Mar-2020, Sanofi announced that "The European Medicines Agency’s Committee for Medicinal Products for Human Use (CHMP) has adopted a positive opinion for Sarclisa®...

Detect COVID-19 in as little as 5 minutes-Abbott’s new diagnostic kit

On 27-Mar-2020, "Abbott has received emergency use authorization (EUA) from the U.S. Food and Drug Administration (FDA) for the fastest available molecular point-of-care test...

Novartis and life sciences companies commit expertise and assets to the fight against COVID-19 pandemic alongside Bill & Melinda Gates Foundation

On 26-Mar-2020, Novartis and a consortium of life sciences companies announced an important collaboration to accelerate the development, manufacture and delivery of vaccines,...

Short note on Plasma therapy- a new approach to treat novel coronavirus (COVID19)

It is reported in many reports that china has used plasma to treat coronavirus infected patients and achieved success in many patients. Plasma is...

Coronavirus: COVID-19 and information Source

COVID-19: The full form of this disease is Coronavirus Infectious Disease 2019 which is caused by Coronavirus. Coronavirus: It's named that because it has...
- Advertisment -

Most Read